Oppenheimer & Co’s Cellectis CLLS Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q2 | – | Sell |
-133,890
| Closed | -$355K | – | 1444 |
|
2024
Q1 | $355K | Buy |
133,890
+747
| +0.6% | +$1.98K | 0.01% | 1115 |
|
2023
Q4 | $410K | Buy |
133,143
+11,723
| +10% | +$36.1K | 0.01% | 1031 |
|
2023
Q3 | $192K | Buy |
121,420
+3,731
| +3% | +$5.9K | ﹤0.01% | 1269 |
|
2023
Q2 | $232K | Buy |
117,689
+1,526
| +1% | +$3K | ﹤0.01% | 1245 |
|
2023
Q1 | $224K | Buy |
116,163
+41,111
| +55% | +$79.3K | ﹤0.01% | 1225 |
|
2022
Q4 | $158K | Sell |
75,052
-16,911
| -18% | -$35.5K | ﹤0.01% | 1255 |
|
2022
Q3 | $211K | Buy |
91,963
+16,330
| +22% | +$37.5K | ﹤0.01% | 1212 |
|
2022
Q2 | $214K | Buy |
75,633
+979
| +1% | +$2.77K | ﹤0.01% | 1239 |
|
2022
Q1 | $339K | Buy |
+74,654
| New | +$339K | 0.01% | 1147 |
|
2018
Q4 | – | Sell |
-27,499
| Closed | -$776K | – | 1261 |
|
2018
Q3 | $776K | Sell |
27,499
-2,363
| -8% | -$66.7K | 0.02% | 684 |
|
2018
Q2 | $845K | Buy |
+29,862
| New | +$845K | 0.02% | 653 |
|
2016
Q4 | – | Sell |
-10,604
| Closed | -$255K | – | 1292 |
|
2016
Q3 | $255K | Sell |
10,604
-1,497
| -12% | -$36K | 0.01% | 1045 |
|
2016
Q2 | $322K | Sell |
12,101
-234
| -2% | -$6.23K | 0.01% | 943 |
|
2016
Q1 | $339K | Sell |
12,335
-1,462
| -11% | -$40.2K | 0.01% | 889 |
|
2015
Q4 | $428K | Buy |
13,797
+1,080
| +8% | +$33.5K | 0.01% | 823 |
|
2015
Q3 | $335K | Buy |
12,717
+7,081
| +126% | +$187K | 0.01% | 954 |
|
2015
Q2 | $203K | Buy |
+5,636
| New | +$203K | 0.01% | 1293 |
|